Atrial Fibrillation (AFib) Treatment in Hyderabad

Understanding Atrial Fibrillation

The heart's normal rhythm is controlled by the sinoatrial (SA) node, a small cluster of cells in the right atrium that fires a regular electrical impulse, causing the atria to contract and push blood into the ventricles. In atrial fibrillation, multiple areas of the atria generate erratic electrical impulses simultaneously, overriding the SA node. The atria quiver rather than contract properly, and the ventricles beat irregularly in response.

AFib can be intermittent (paroxysmal, stopping on its own within seven days), persistent (lasting more than seven days and requiring treatment to restore normal rhythm), or permanent (when normal rhythm cannot be restored or the decision is made to accept AFib and control heart rate instead). The type of AFib affects which treatment approach is most appropriate.

Symptoms of Atrial Fibrillation

Symptoms vary widely. Some patients are acutely aware of every episode; others, particularly older adults, have no symptoms at all and AFib is found incidentally on a routine ECG.

• Palpitations:
  A sensation of the heart fluttering, racing, or beating irregularly. This is the most commonly reported symptom and can be sudden in onset.
• Breathlessness:
  Particularly during activity. Occurs because the irregular rhythm reduces the heart's pumping efficiency.
• Fatigue:
  Persistent tiredness, even with normal activity, due to reduced cardiac output.
• Dizziness or lightheadedness:
  A feeling of faintness, particularly at the onset of an AFib episode.
• Chest discomfort:
  A vague sensation of pressure or discomfort, distinct from typical angina.
• Reduced exercise tolerance:
  Difficulty sustaining physical activity that was previously manageable.
• No symptoms (silent AFib):
  A significant proportion of AFib, particularly in older adults, is asymptomatic and discovered during investigation for stroke or a routine check-up.

Causes and Risk Factors for AFib

• Hypertension
  The single most common risk factor for AFib worldwide. Chronic high blood pressure enlarges and stiffens the atria over time.
• Heart Valve Disease
  Mitral valve disease in particular is closely associated with AFib due to the resulting atrial enlargement.
• Coronary Artery Disease
  Reduced blood supply to the heart muscle can trigger arrhythmias including AFib.
• Heart Failure
  The enlarged, stressed heart in heart failure is prone to developing AFib, and the two conditions frequently coexist.
• Thyroid Overactivity (Hyperthyroidism)
  An overactive thyroid raises heart rate and can precipitate AFib. A thyroid function test is routine in AFib workup.
• Diabetes
  Increases AFib risk through effects on the autonomic nervous system and cardiac structure.
• Obesity
  Excess body weight is an independent risk factor for AFib and is directly linked to atrial enlargement.
• Sleep Apnea
  Repeated nighttime oxygen drops from obstructive sleep apnea are a major and underdiagnosed trigger for AFib.
• Excessive Alcohol
  Acute heavy alcohol consumption can trigger episodes (holiday heart syndrome). Chronic heavy use damages cardiac muscle.
• Age
  AFib prevalence roughly doubles with each decade of life above age 50.

Diagnosing Atrial Fibrillation

Diagnosis is made by recording the heart's electrical activity during an episode. Because AFib can be intermittent, a standard resting ECG may miss it if performed when the patient is in normal rhythm.

• Resting ECG:
  If the patient is in AFib at the time of recording, the diagnosis is immediately apparent from the irregular rhythm and absent P waves.
• Holter Monitor (24 to 48 hours):
  A portable ECG worn continuously for one to two days to capture episodes that occur during daily activities.
• Event Monitor (30 days):
  Used when symptoms are infrequent. The patient activates the recorder when symptoms occur, and the device transmits data for review.
• 2D Echocardiography:
  2D echo assesses atrial size, valve function, and overall heart function. Enlarged atria or valve disease suggests a structural cause.
• Blood Tests:
  Thyroid function, full blood count, kidney function, and liver function tests are standard to identify treatable underlying causes.
• Electrophysiology Study:
  In selected patients being considered for ablation, a formal EP study maps the electrical activity of the atria to identify ablation targets.

Treatment Options for Atrial Fibrillation

Rate Control

Rate control aims to slow the ventricular rate during AFib without necessarily restoring normal sinus rhythm. Medications used include beta-blockers, calcium channel blockers, and digoxin. Rate control is appropriate for patients with permanent AFib or those who are not candidates for rhythm control.

Rhythm Control

Rhythm control aims to restore and maintain normal sinus rhythm (cardioversion). This can be achieved with antiarrhythmic medications or electrical cardioversion (a brief, controlled electric shock under sedation that resets the heart's rhythm). Rhythm control is preferred for younger patients, those with significant symptoms, and those who do not tolerate rate control well.

Radiofrequency Ablation

Radiofrequency ablation (RFA) is a catheter-based procedure that eliminates the abnormal electrical triggers driving AFib. Most AFib originates from electrical pulses firing from the pulmonary veins (the veins that bring oxygenated blood from the lungs to the left atrium). The procedure involves threading catheters into the heart and delivering radiofrequency energy to create small scars around the pulmonary vein openings, isolating the triggers from the rest of the atrium. Ablation offers the best chance of long-term freedom from AFib, particularly in patients with paroxysmal or early persistent AFib.

Stroke Prevention with Blood Thinners

Anticoagulation therapy is the cornerstone of AFib management for most patients, regardless of whether rate or rhythm control is chosen. Blood thinners (warfarin or newer direct oral anticoagulants such as apixaban, rivaroxaban, or dabigatran) reduce stroke risk by preventing clot formation in the left atrium. The decision to anticoagulate is guided by the CHA2DS2-VASc score, a validated risk calculator based on age, gender, and comorbidities.

Device Therapy

Some patients with AFib and associated bradycardia (slow heart rate) may require pacemaker implantation to ensure an adequate heart rate, particularly if antiarrhythmic or rate-controlling medications slow the heart excessively.